Lv2
120 积分 2024-02-17 加入
Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy
16小时前
求助中
Step-by-Step Approach to Intracorporeal Urinary Diversion, Ileal Conduit, and W-Neobladder: The Roswell Park Technique
1个月前
已完结
Re-Rechallenge 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
2个月前
已完结
Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
2个月前
已完结
Short-term Prostate-specific Antigen Pseudoregression Following [177Lu]–Prostate-specific Membrane Antigen Therapy
2个月前
已完结
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2个月前
已完结
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
2个月前
已完结
Health-related quality of life, pain, and symptomatic skeletal events with [177Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial
3个月前
已完结
177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
3个月前
已完结
The Efficacy and Safety of Hyperthermia Intravesical Chemotherapy in the Treatment of Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis
3个月前
已完结
皖公网安备34019202002308
